Details for New Drug Application (NDA): 206890
NDA 206890 describes ILOPERIDONE, which is a drug marketed by Adaptis, Lupin, and Taro, and is included in three NDAs. It is available from one supplier. Additional details are available on the ILOPERIDONE profile page.
The generic ingredient in ILOPERIDONE is iloperidone. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the iloperidone profile page.
The generic ingredient in ILOPERIDONE is iloperidone. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the iloperidone profile page.
Summary for 206890
| Tradename: | ILOPERIDONE |
| Applicant: | Lupin |
| Ingredient: | iloperidone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | May 5, 2022 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | May 5, 2022 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | May 5, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
